954. Use of 5-fluorocytosine in systemic candidiasis in infancy. Three cases of systemic candidiasis were successfully treated with 5-fluorocytosine (5-FC), an antifungal agent. The fungaemia developed during continuous intravenous alimentation for intestinal malabsorption. The diagnosis was confirmed by repeated positive cultures from blood, urine, and faeces. The fungus was also grown from cultures of intravenous solutions and catheters. The clinical features varied and included unexplained fever, oedema, stupor, tachypnoea, convulsions, hepatosplenomegaly, and congestive heart failure. The clinical symptoms receded rapidly and the cultures became negative after oral or intravenous treatment with 5-FC.
There was oral moniliasis. Laboratory investigations are noted in Table I . Esch. coli 0114 was isolated from his faeces, and, on the assumption that this infection was systemic as well as local, colistin was given orally and kanamycin systemically.
As malabsorption was suspected-and subsequently substantiated by the sugar tolerance tests-casein hydrolysate ('Amigen', Travenol Inc.), supplemented twice weekly by an infusion of blood or plasma, was given. In order to raise the caloric intake of the patient, a 50% glucose solution was added to the infusion bottle, to a final concentration of 10% glucose. Calcium, magnesium, and vitamins were given intramuscularly. This therapy was given continuously. As the diarrhoea continued even after oral feeding was stopped, a persistent infection was assumed. The emergence in the faeces of another strain of Esch. coli, 0126, as well as Entamoeba histolytica necessitated the introduction of other antibiotics and di-iodohydroxquinolone. Thereafter, no further pathogenic organisms could be obtained from the stools but the infant's condition deteriorated. In the absence of any change in the daily fluid intake, the infant suddenly gained weight, and generalized oedema with hepatosplenomegaly appeared (see Table II ), accompanied by spiky fever. Extensive Table III ). Blood or plasma was added once or twice weekly as a supply of trace elements and to repair anaemia. Antibiotics were not given.
After 36 days of hospitalization, while the patient was improving gradually, we were alerted by the appearance of spiky fever, accompanied by excessive weight gain, oedema, and hepatosplenomegaly. Tachycardia as well as bouts of tachypnoea alternating with apnoea appeared. The child looked ashen-grey, stuporose, and had a constant tremor of the upper limbs. Two days later he had a series of convulsions in the course of 2 days. EEG and echoencephalogram were normal. On blood and urine cultures Candida albicans was isolated (Table III) .
Because of the rapid deterioration, 5-FC was started intravenously in a dosage of 100 mg/kg per day. Later, as clinical improvement appeared, it was given orally. In addition, the patient received a course of cephaloridine parenterally, 270 mg/kg per day for 10 days. His condition improved promptly and within 10 days all the above-mentioned acute symptoms cleared and consciousness returned. Diarrhoea continued. Treatment with 5-FC was continued for 60 days. He was discharged after 107 days in hospital, weighing 4710 g and eating a full diet. 5 -
S Discussion
The diagnosis of systemic candidiasis must be based on (1) positive cultures for candida, (2) suspicious clinical features, (3) the presence of predisposing factors, and (4) a good response to specific antifungal treatment given early in the disease.
Due to its ubiquity, the recovery of candida from sputum, stool, vagina, or even umbilical stump may have no significance (Toala et al., 1970) . Even candida in the blood-stream or urine may represent a transient contamination which the body can overcome without the aid of drugs (Ellis and Spivack, 1967) . Occasionally, fungaemia may occur before death without clinical evidence of disseminated candidiasis. Candiduria can also be a transient phenomenon, but, if persistent, may represent an indicator of disseminated candidiasis (Ellis and Spivack, 1967) .
When candida has been repeatedly isolated from blood and urine in the presence of symptoms compatible with systemic fungal infection, this diagnosis must be seriously considered. Though no typical features of disseminated candidiasis have been described, the 3 cases reported here showed a number of features common to all (see Table II ).
The predominant symptoms in our first case were fever, oedema, hepatomegaly, together with clinical EEG and echoencephalographic evidence of an intracranial space-occupying lesion (see Fig. 1 ). After treatment there was a regression of the systemic as well as the neurological signs. The return to normal of the EEG and echoencephalograms after the institution of antifungal therapy would be consistent with the diagnosis of candida granuloma in the right cerebral hemisphere. In our second case the predominant clinical features, in addition to fever, stupor, and tachypnoea, were congestive heart failure with hepatosplenomegaly and oedema. The congestive heart failure was considered to be due to cardiac involvement by the infecting fungus, as the clinical signs improved on antifungal therapy.
The third case had spiky fever, tachypnoea alternating with apnoea, hepatosplenomegaly, unexplained excessive weight gain, stupor, and convulsions. In this case EEG and echoencephalograms were normal.
Although Skobel, Schabinski, and Essigke (1956) found that 9% of healthy babies under 3 months of age had antibodies to candida, it is possible that rising anticandida titres, as were seen in all our patients, may have a diagnostic value (Miller, 1967) . The low titre of anticandida antibodies and their rapid decrease after treatment may also reflect the effectiveness of 5-FC on these short-lived infections. Murray, Buckley, and Turner (1969) thought that precipitins to candida in a relatively high titre may be helpful in the diagnosis of systemic candidiasis, while Pepys et al. (1968) noted that precipitins against protein antigens of candida albicans are relatively common in asthmatic patients without clinical evidence of candidiasis.
The incidence of severe systemic candidiasis is increasing as a result of modern medical therapy, such as the use of broad-spectrum antibiotics, immunosuppressive drugs, or the use of intravenous catheters for prolonged intravenous alimentation.
The observations of Cormane and Goslings (1963) and Boeckman and Krill (1970) suggested that solutions of amino acids and glucose may be particularly favourable media for the growth of candida, the richness of growth being proportional to the concentration of glucose.
Despite the difficulties and dangers in its use, amphotericin-B is still widely used in disseminated candidiasis. In a search for new antifungal agents less toxic than amphotericin-B, 5-FC, among others, was found to be effective against systemic candidiasis as well as against other fungal infections (Grunberg et al., 1963; Scholer, 1970; Davies and Reeves, 1971) . 5-Fluorocytosine (RO29915/Bl), an antimetabolite of the pyrimidine base cytosine, shows a high degree of activity against candida species, especially Candida albicans. It is not detectably metabolized and is mostly excreted in the urine in an unchanged form. The drug was shown to have a pronounced effect on intravenously administered candida infection in mice, and there have been reports of its successful use in fungal infection in man. The minimum inhibitory concentration of 5-FC reported for candida species ranged from 0o23 to 3 9 mg/ml (Shadomy, 1969) .
To the best of our knowledge, this is the first trial of 5-FC for systemic candidiasis in infants. Furthermore, the intravenous administration of the drug, as given in our third case, has not been previously described. In this patient the intravenous administration of the drug enabled us to overcome possibly insufficient assimilation due to the patient's malabsorption syndrome. Even with oral therapy, however, a sufficient amount of the drug was obviously absorbed in the other two cases, resulting in cure without the need for discontinuing intravenous alimentation.
Apart from prompt improvement in the general condition and rapid disappearance of clinical features, the second and third cultures taken after the institution of therapy with 5-FC in our first and third cases, respectively, were negative and remained so subsequently. The treatment was continued at a dosage of 200 mg/kg per day for periods up to 12 weeks. Sensitivity studies should always be undertaken before and during therapy with 5-FC since there are reports of resistance to 5-FC in isolates of Candida albicans from patients receiving the drug (Shadomy, 1969) .
By meticulous care it should be possible to prevent candida superinfection in patients receiving prolonged intravenous nutrition. Numerous reports of this complication, however, show that this ideal is not easily achieved (Groff, 1969; Record et al., 1971; Boeckman and Krill, 1970) . The advantage of effective antifungal therapy must not take the place of prophylactic measures such as the use of local application of antiseptic and antimycotic solutions to the puncture site, daily changing of the infusion set, and the use of a millipore filter between the patient and the infusion bottle.
